Immunome (IMNM) Stock Insights

IMNM price $18.54 -0.23 -1.25%

Ticker
IMNM
Price
$18.54
Change
-0.23 -1.25%
Market cap ?
$2.19B
P/E ?
-7.04
Forward P/E ?
25.39
Dividend yield ?
0.00%
Beta ?
2.13
Sector
Healthcare
Industry
Biotechnology

Financials

20182019202020212022202320242025
000001401800090410006941000

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan…

Fair value

IMNM fair value $17.14. Price $18.54. Price is 8% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 739.71K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 118.00M. Net debt -649.63M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare IMNM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.61—153.85K
2026-08-11-0.65-0.51—166.67K
2026-05-12-0.48-0.60—222.22K
2026-03-03-0.75-0.59—876.03K
2025-11-06-0.65-0.57—850.00K
2025-08-06-0.50-0.524.01M833.33K
2025-05-12-0.52-0.662.93M457.14K
2025-03-19-0.84-0.682.74M3.15M
2024-11-13-0.78-0.602.91M3.16M
2024-08-12-0.49-0.382.36M2.55M
2024-05-14-2.51-0.691.03M2.80M
2024-03-28-4.21-0.283.84M2.07M
2023-11-09-0.36-0.173.56M3.56M
2023-08-09-0.46-0.164.26M—
2023-05-05-0.350.592.36M—
2023-03-16-0.640.67——
2022-11-14-0.75-0.76——
2022-08-05-0.74-0.75——
2022-05-12-0.96-0.69——
2022-03-28-0.66-0.81——
2021-11-15-0.65-0.50——
2021-08-16-0.46-0.39—4.70M
2021-05-12-0.37-0.41——
2021-03-25-0.40-0.29——
2020-11-16-7.52-0.38——
2020-10-05-0.29———
2020-03-31-0.47———
2019-12-31-0.51———
2019-09-30-0.48———
2019-06-30-2.19———
2019-03-31-2.19———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-11Higgins JackBuy18.00K$1.3524.30K
2026-09-11Higgins JackBuy18.00K$1.3524.30K
2026-09-11Higgins JackSell13.20K$25.32334.22K
2026-09-11Higgins JackSell8.80K——
2026-08-12Barchas IsaacSell11.05K$27.25301.06K
2026-08-11Barchas IsaacSell62.29K$26.231.63M
2026-08-10Barchas IsaacSell10.12K$26.07263.96K
2026-08-07Barchas IsaacSell15.25K$26.06397.36K
2026-08-06Barchas IsaacSell20.84K$26.06543.09K
2026-08-04Horn KinneySell40.25K$10.60426.65K
2026-08-04Horn KinneyBuy40.25K$10.60426.65K
2026-08-04Horn KinneySell50.37K$12.92650.73K
2026-08-04Horn KinneyBuy50.37K$12.92650.73K
2026-08-04Horn KinneySell90.62K$25.092.27M
2026-07-23Horn KinneyBuy62.50K$22.011.38M
2026-07-23Horn KinneyBuy31.25K——
2026-07-23Tsai PhilipBuy38.25K——
2026-07-23Tsai PhilipBuy76.50K$22.011.68M
2026-07-23Stoneman Sandra G.Buy76.50K$22.011.68M
2026-07-23Stoneman Sandra G.Buy38.25K——
2026-07-23Higgins JackBuy76.50K$22.011.68M
2026-07-23Higgins JackBuy38.25K——
2026-07-23Rosett MaxBuy47.25K——
2026-07-23Rosett MaxBuy94.50K$22.012.08M
2026-07-23Lechleider RobertBuy108.00K$22.012.38M
2026-07-23Lechleider RobertBuy54.00K——
2026-07-23SIEGALL CLAY BBuy180.00K——
2026-07-23SIEGALL CLAY BBuy360.00K$22.017.92M
2026-07-07Horn KinneySell1.09K$12.9214.11K
2026-07-07Horn KinneyBuy1.09K$12.9214.11K
2026-07-07Horn KinneySell1.09K$25.0027.30K
2026-07-07Barchas IsaacSell16.91K$24.20409.13K
2026-07-06Barchas IsaacSell83.09K$24.112.00M
2026-07-02Lechleider RobertSell55.00K$8.73480.15K
2026-07-02Lechleider RobertBuy55.00K$8.73480.15K
2026-07-02Lechleider RobertSell22.71K$21.95498.57K
2026-07-02Lechleider RobertSell16.21K$22.76369.03K
2026-07-02Lechleider RobertSell16.07K$23.44376.73K
2026-07-02Barchas IsaacSell75.67K$22.351.69M
2026-07-02Barchas IsaacSell24.34K$23.33567.74K
2026-06-30Barchas IsaacSell101.05K$21.122.13M
2026-06-25Lechleider RobertSell55.00K$8.73480.15K
2026-06-25Lechleider RobertBuy55.00K$8.73480.15K
2026-06-25Lechleider RobertSell40.58K$19.56793.74K
2026-06-25Lechleider RobertSell14.42K$20.66297.92K
2026-06-15Rosett MaxBuy60.00K$1.0563.00K
2026-06-15Rosett MaxSell60.00K$18.231.09M
2026-06-15Rosett MaxSell60.00K$1.0563.00K
2026-06-10SWAIN SANDRA MBuy9.90K$18.16179.73K
2026-06-10WAGENHEIM PHILIPBuy9.90K$18.16179.73K
2026-06-10BIENAIME JEAN JACQUESBuy9.90K$18.16179.73K
2026-06-10Boylan James PBuy9.90K$18.16179.73K
2026-06-10Barchas IsaacBuy9.90K$18.16179.73K
2026-06-10SCHAFER CAROLBuy9.90K$18.16179.73K
2026-06-05BIENAIME JEAN JACQUESBuy1.00K$19.2719.27K
2026-06-05BIENAIME JEAN JACQUESSell500$19.449.72K
2026-06-05BIENAIME JEAN JACQUESBuy3.50K$19.4668.11K
2026-06-05BIENAIME JEAN JACQUESBuy6.00K$19.48116.88K
2026-06-05BIENAIME JEAN JACQUESSell10.00K$19.41194.10K
2026-05-15BIENAIME JEAN JACQUESBuy5.00K$20.70103.50K
2026-04-02Higgins JackSell9.44K$21.64204.24K
2026-04-02Rosett MaxBuy39.71K$1.3553.61K
2026-04-02Rosett MaxBuy31.85K$1.0533.44K
2026-04-02Rosett MaxSell31.85K$1.0533.44K
2026-04-02Rosett MaxSell63.66K$21.911.39M
2026-04-02Rosett MaxSell1.34K$22.4830.21K
2026-04-02Rosett MaxSell39.71K$1.3553.61K
2026-03-30Higgins JackSell6.29K——
2026-03-27SIEGALL CLAY BBuy25.45K$19.67500.60K
2026-03-23WAGENHEIM PHILIPSell28.20K$20.65582.33K
2026-03-20WAGENHEIM PHILIPSell36.80K$20.47753.30K
2026-03-11BIENAIME JEAN JACQUESBuy1.00K$21.5521.55K
2026-03-10BIENAIME JEAN JACQUESBuy1.00K$22.1222.12K
2025-12-30SIEGALL CLAY BBuy4.73K$21.15100.02K
2025-12-22Barchas IsaacSell371.95K$21.728.08M
2025-12-22Barchas IsaacSell11.25K$22.34251.35K
2025-12-19Higgins JackSell1.00K——
2025-12-19Higgins JackSell1.00K——
2025-12-19Higgins JackSell1.00K——
2025-12-19Higgins JackBuy1.00K——
2025-12-19SIEGALL CLAY BBuy7.28K$20.48149.05K
2025-12-19SIEGALL CLAY BSell200.00K——
2025-12-19Tsai PhilipBuy10.00K$20.49204.90K
2025-12-18SIEGALL CLAY BBuy46.51K$21.50999.99K
2025-09-10Higgins JackSell22.00K$1.3529.70K
2025-09-10Higgins JackBuy22.00K$1.3529.70K
2025-07-29Tsai PhilipBuy190.00K$10.602.01M
2025-07-29Rosett MaxBuy207.00K$10.602.19M
2025-07-29Lechleider RobertBuy242.00K$10.602.57M
2025-07-29Horn KinneyBuy161.00K$10.601.71M
2025-07-29Higgins JackBuy196.00K$10.602.08M
2025-07-29SIEGALL CLAY BBuy800.00K$10.608.48M
2025-07-29Stoneman Sandra G.Buy190.00K$10.602.01M
2025-06-10Boylan James PBuy18.86K$9.57180.53K
2025-06-10SCHAFER CAROLBuy18.86K$9.57180.53K
2025-06-10WAGENHEIM PHILIPBuy18.86K$9.57180.53K
2025-06-10Barchas IsaacBuy18.86K$9.57180.53K
2025-06-10BIENAIME JEAN JACQUESBuy18.86K$9.57180.53K
2025-06-10SWAIN SANDRA MBuy18.86K$9.57180.53K
2025-06-03BIENAIME JEAN JACQUESBuy5.00K$9.3846.90K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 211, holders +3 vs prior quarter. Ownership 104.99%.

HolderSharesChangeChange %Value
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.19.68M3.31M+20.24%416.95M
FMR LLC16.99M17.60K+0.10%359.97M
BLACKROCK, INC.8.81M636.82K+7.80%186.59M
STATE STREET CORP5.49M94.72K+1.75%116.43M
WELLINGTON MANAGEMENT GROUP LLP5.21M478.24K+10.11%110.40M
REDMILE GROUP, LLC4.91M-647.29K-11.64%104.08M
PRIMECAP MANAGEMENT CO/CA/4.58M-206.80K-4.32%97.08M
VANGUARD CAPITAL MANAGEMENT LLC4.55M121.59K+2.74%96.44M
DRIEHAUS CAPITAL MANAGEMENT LLC4.35M246.24K+6.01%92.09M
ENAVATE SCIENCES GP, LLC3.61M00.00%76.58M
GEODE CAPITAL MANAGEMENT, LLC2.75M194.22K+7.58%58.39M
MORGAN STANLEY2.41M-433.65K-15.26%51.02M
SILVERARC CAPITAL MANAGEMENT, LLC2.02M166.73K+9.01%42.74M
JPMORGAN CHASE & CO1.85M-929.29K-33.45%38.99M
PRICE T ROWE ASSOCIATES INC /MD/1.77M-1.09M-37.97%37.58M
SOFINNOVA INVESTMENTS, INC.1.72M18.41K+1.08%36.45M
READYSTATE ASSET MANAGEMENT LP1.61M303.96K+23.35%34.03M
GOLDMAN SACHS GROUP INC1.51M411.01K+37.31%32.05M
VANGUARD PORTFOLIO MANAGEMENT LLC1.35M342.00K+33.96%28.58M
PRINCIPAL FINANCIAL GROUP INC1.35M-29.51K-2.14%28.55M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.1.25M152.44K+13.89%26.49M
WOODLINE PARTNERS LP1.00M-575.00K-36.50%21.20M
NORTHERN TRUST CORP968.35K69.20K+7.70%20.52M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.886.19K886.19KNew18.78M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC886.19K34.40K+4.04%18.78M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Immunome (IMNM) Stock Insights

IMNM$18.54-0.23 -1.25%

$2.19B

Market Cap

-7.04

P/E

25.39

Forward P/E

—

Score

Price History